Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.85 - $1.41 $267,203 - $443,243
-314,357 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.16 - $2.5 $710,713 - $1.53 Million
-612,684 Reduced 66.09%
314,357 $415,000
Q4 2021

Feb 11, 2022

BUY
$2.46 - $8.74 $2.28 Million - $8.1 Million
927,041 New
927,041 $2.28 Million
Q1 2019

May 14, 2019

SELL
$0.94 - $1.16 $9,870 - $12,180
-10,500 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$0.92 - $1.31 $9,660 - $13,755
10,500 New
10,500 $10,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $91.9M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.